Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000230245 | SCV000286287 | likely benign | Pancreatic adenocarcinoma | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020778 | SCV002743876 | uncertain significance | not specified | 2022-10-30 | criteria provided, single submitter | clinical testing | The p.R891H variant (also known as c.2672G>A), located in coding exon 15 of the PALLD gene, results from a G to A substitution at nucleotide position 2672. The arginine at codon 891 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |